Cargando…
HIV-1 Escape from Small-Molecule Antagonism of Vif
The HIV-1 accessory protein Vif, which counteracts the antiviral action of the DNA-editing cytidine deaminase APOBEC3G (A3G), is an attractive and yet unexploited therapeutic target. Vif reduces the virion incorporation of A3G by targeting the restriction factor for proteasomal degradation in the vi...
Autores principales: | Sharkey, Mark, Sharova, Natalia, Mohammed, Idrees, Huff, Sarah E., Kummetha, Indrasena Reddy, Singh, Gatikrushna, Rana, Tariq M., Stevenson, Mario |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6391917/ https://www.ncbi.nlm.nih.gov/pubmed/30808702 http://dx.doi.org/10.1128/mBio.00144-19 |
Ejemplares similares
-
Small-molecule PTPN2 Inhibitors Sensitize Resistant Melanoma to Anti-PD-1 Immunotherapy
por: Zhu, Zhouting, et al.
Publicado: (2023) -
Rational Design
and Optimization of m(6)A-RNA
Demethylase FTO Inhibitors as Anticancer Agents
por: Huff, Sarah, et al.
Publicado: (2022) -
Structural basis of antagonism of human APOBEC3F by HIV-1 Vif
por: Hu, Yingxia, et al.
Publicado: (2019) -
The structural basis for HIV-1 Vif antagonism of human APOBEC3G
por: Li, Yen-Li, et al.
Publicado: (2023) -
Discovery and Mechanism
of SARS-CoV-2 Main
Protease Inhibitors
por: Huff, Sarah, et al.
Publicado: (2021)